Literature DB >> 25477210

Regulation of T cell development by c-Cbl: essential role of Lck.

Y Jeffrey Chiang1, Richard J Hodes2.   

Abstract

A canonical pre-TCR/TCR signaling pathway critical for thymic T cell development involves sequential phosphorylation and signaling through Lck, Zap70, Lat and Slp76. However, we and others have previously reported that genomic deletion of c-Cbl (Cbl) partially or completely reverses the defects in thymic development in mice deficient in Zap70, Slp76, Lat or Vav1, indicating the presence of alternative pathways normally suppressed by Cbl. To further elucidate pre-TCR/TCR signaling pathways involved in thymic development, we characterized the effect of Cbl inactivation on developmental and signaling defects in mice deficient in proximal signaling molecules Lck and Zap70. Inactivation of Cbl partially reversed defective T cell development in Zap70 (-/-) mice and reversed defects in phosphorylation of Erk, Plc-γ1, Vav1 and Akt, in TCR-stimulated Cbl (-/-) Zap70 (-/-) thymocytes. Recent reports identified an essential role of Lck in associating with CD4 and CD8 coreceptors and mediating the requirement for MHC restriction in TCR recognition. Since TCR recognition has been shown to be MHC-restricted in Cbl (-/-) mice, it was of interest to determine whether the requirement for Lck remained unmodified by Cbl deletion. Indeed, in contrast to the effect of Cbl inactivation in partially or fully bypassing requirements for other TCR signaling components, inactivation of Cbl did not reverse either defective T cell development or defective phosphorylation of TCR signaling molecules in Lck (-/-) mice. Thus, Lck, which plays a unique role in enforcing MHC restriction, is essential for thymic development in presence or absence of Cbl, ensuring MHC restriction of T cells derived from either pathway. Published by Oxford University Press on behalf of The Japanese Society for Immunology 2014.

Entities:  

Keywords:  Cbl; Lck; T cell receptor; ZAP70; thymic development

Mesh:

Substances:

Year:  2014        PMID: 25477210      PMCID: PMC4406264          DOI: 10.1093/intimm/dxu105

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  24 in total

1.  Cbl-b regulates the CD28 dependence of T-cell activation.

Authors:  Y J Chiang; H K Kole; K Brown; M Naramura; S Fukuhara; R J Hu; I K Jang; J S Gutkind; E Shevach; H Gu
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

2.  RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.

Authors:  C B Thien; F Walker; W Y Langdon
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

Review 3.  The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation.

Authors:  Rose Zamoyska; Albert Basson; Andrew Filby; Giuseppe Legname; Matthew Lovatt; Benedict Seddon
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

4.  Requirement for tyrosine kinase p56lck for thymic development of transgenic gamma delta T cells.

Authors:  J Penninger; K Kishihara; T Molina; V A Wallace; E Timms; S M Hedrick; T W Mak
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

Review 5.  The SLP-76 family of adapter proteins.

Authors:  Jennifer N Wu; Gary A Koretzky
Journal:  Semin Immunol       Date:  2004-12       Impact factor: 11.130

6.  ATM influences the efficiency of TCRβ rearrangement, subsequent TCRβ-dependent T cell development, and generation of the pre-selection TCRβ CDR3 repertoire.

Authors:  Karen S Hathcock; Steven Bowen; Ferenc Livak; Richard J Hodes
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

7.  A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase.

Authors:  Christine B F Thien; Robin M Scaife; John M Papadimitriou; Maria A Murphy; David D L Bowtell; Wallace Y Langdon
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

8.  Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.

Authors:  Keiko Fujikawa; Ana V Miletic; Frederick W Alt; Roberta Faccio; Tracie Brown; Jeremy Hoog; Jessica Fredericks; Shinzo Nishi; Shirly Mildiner; Sheri L Moores; Joan Brugge; Fred S Rosen; Wojciech Swat
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

9.  Inactivation of c-Cbl reverses neonatal lethality and T cell developmental arrest of SLP-76-deficient mice.

Authors:  Y Jeffrey Chiang; Connie L Sommers; Martha S Jordan; Hua Gu; Lawrence E Samelson; Gary A Koretzky; Richard J Hodes
Journal:  J Exp Med       Date:  2004-07-05       Impact factor: 14.307

10.  ERK positive feedback regulates a widespread network of tyrosine phosphorylation sites across canonical T cell signaling and actin cytoskeletal proteins in Jurkat T cells.

Authors:  Ynes A Helou; Vinh Nguyen; Samantha P Beik; Arthur R Salomon
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more
  3 in total

1.  Type of PaperY192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection.

Authors:  Matthias Kästle; Camilla Merten; Roland Hartig; Carlos Plaza-Sirvent; Ingo Schmitz; Ursula Bommhardt; Burkhart Schraven; Luca Simeoni
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  T-cell development is regulated by the coordinated function of proximal and distal Lck promoters active at different developmental stages.

Authors:  Y Jeffrey Chiang; Richard J Hodes
Journal:  Eur J Immunol       Date:  2016-08-29       Impact factor: 5.532

3.  Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.

Authors:  Fei Yuan; Yu-Hang Zhang; Xiang-Yin Kong; Yu-Dong Cai
Journal:  Biomed Res Int       Date:  2017-02-14       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.